Powder Delivery TRIZ Cases

Engineered N-linked Fc glycosylation enables site-specific antibody conjugation while preserving structure, stability, and antigen binding.

Micelle-forming surfactant formulations improve cannabinoid solubility, stability, and skin permeation for sustained transdermal dosing.

Arginine, surfactants, and sucrose stabilize recombinant Sclerotium rolfsii lectins, preserving bioactivity and shelf life in liquid or lyophilized form.

Crystalline form B treosulfan with controlled freeze-drying cuts reconstitution time while improving purity, stability, and batch consistency.

Biodegradable film laminates balance sealability, strength, and moisture resistance for wrapped solid dosage units while composting within 90 days.

A host-cell-mediated lyophilized composition preserves fragile protozoa through freeze-drying and rehydration while retaining viability and infectivity.

Nanoparticle eye formulations use amphiphilic block copolymers and targeting moieties to improve retention, penetration, and sustained release.

Radiation-cleavable S-nitrosothiol prodrugs and nanoparticle delivery boost tumor radiosensitivity while limiting systemic toxicity.

Antigen-loaded nanogel pretreatment boosts T cell infusion efficacy against immune checkpoint inhibitor-resistant tumors.

PEI nanogels switch with salt concentration to protect molecules through digestion and release them at physiological conditions.

Gd3+/Bi3+ nanoparticles combine MRI and CT imaging with local radiation dose amplification to improve tumor targeting and limit healthy-tissue toxicity.

Controlled pH emulsion or precipitation creates highly negative PLGA particle surfaces, improving biocompatibility and API attachment.

A brain-internalizing nanoparticle with asymmetric polymer linkers carries drugs across the BBB while preserving agent activity.

Electrosprayed particles enable high-concentration therapeutic or diagnostic formulations with lower viscosity, better injectability, and improved stability.

Biodegradable radiopaque particles in poppy seed oil localize embolization, enable imaging, and sustain drug release to limit systemic exposure.

GC-rich 5' UTR elements in modified mRNA increase 43S complex residence time to improve correct start-codon selection and reduce aberrant translation.

Size-tunable synthetic particles combine CD3 and co-stimulatory ligands to activate and expand T cells with fewer cells and lower immune reaction risk.

External magnetic fields steer nasal formulations to improve biomarker capture and retrieval for quantitative analysis of tau and beta-amyloid.

A lipid-based low-water filling dissolves nicotine in oil to preserve mouthfeel while limiting oxidation, microbial growth, and flavor loss.

Cationic poloxamers boost viral transduction through electrostatic polymer action, lowering virus dose needs while minimizing cell toxicity.

A specific B. lactis strain is used as bacterial powder or postbiotic to lower brain Aβ42 deposition, clear plaques, and reduce neuroinflammation.

Combining butyrate with turmeric extracts or curcuminoids boosts anti-inflammatory action while lowering cost and reducing high-dose side effects.

Controlled carbamate particle sizing balances rapid oral dissolution with flowability, stability, and uniform dosage performance.

Species-matched rAAV EPO delivery raises circulating EPO in cats and dogs, correcting anemia while avoiding immune reactions.

A lipid-surfactant powder adsorbed on hydrophilic granules forms mixed micelles in the gut to raise PEA bioaccessibility and absorption.

Hydrophobic counterion pairing turns peptides into low-solubility salts that dissolve slowly, enabling sustained release with less formulation complexity.

Breath-synchronized pulsatile iNO delivery improves activity levels in ILD while limiting toxic NO2 formation and side effects.

Low-MOI Vero cell propagation limits E2 mutations during CHIKV-Δ5nsP3 production, preserving immunogenicity and consistent vaccine yield.

High-purity beta-lactoglobulin forms a co-amorphous drug system that improves solubility while preventing re-crystallization.

Excipients and lyophilization stabilize recombinant Sclerotium rolfsii lectin, limiting aggregation and preserving cancer therapy bioactivity.

Silica nanotubes disperse hydrophobic zinc phthalocyanine in water, preserving photoactivity while avoiding costly chemical functionalization.

Combining silk protein with blood plasma or serum improves wound repair through synergy while avoiding the cost and limits of separate treatments.

Amorphous cabozantinib dispersions improve bioavailability and stability while minimizing food effects and supporting more flexible oral dosing.

Aerosolized mitochondria delivered by inhalers or nebulizers enable non-invasive respiratory tract targeting while preserving mitochondrial function.

Fine particle sizing to D90 ≤ 50 µm with selected excipients improves orexin antagonist dissolution, bioavailability, and half-life control.

A lyophilized gelatin-mannitol CBD dosage form dissolves in seconds for mucosal absorption, faster onset, and more consistent dosing.

A citric acid crosslinked CMC hydrogel balances elasticity and fluid absorption to act locally in the colon with minimal side effects.

Above-freezing vacuum drying with stabilizers and protective agents preserves microorganism viability while cutting freeze-drying energy and time.

Silica microspheres enable sustained vaginal drug release that maintains efficacy while reducing skin and mucosal irritation.

Cryogenic vibration milling breaks plant material below 30 μm to release and preserve active substances for more bioavailable granules and tablets.

Arginine, histidine-aspartate or histidine-glutamate buffer, and Poloxamer 188 stabilize high-concentration anti-IL-6 antibody solutions during storage.

Coat oligonucleotides with nuclease-resistant nucleotides protect nucleic acid nanostructures while enabling spatial control and timed drug release.

Engineered disulfide-linked ferritin shells protect oral protein payloads from acidic pH and digestive enzymes while improving intestinal permeability.

A fluorinated PEI core with a heparin shell protects mRNA, improves uptake and endosomal escape, and reduces toxicity in cancer and stem cells.

Electrostatic ionic complexes slow burst release of cationic polypeptides, improving stability, lowering toxicity, and extending dosing intervals.

An engineered anti-GDF15 antibody blocks tumor GDF15, supports T-cell entry, and avoids ADCC and CDC during checkpoint inhibitor therapy.

A rod-shaped DNA origami carrier uses electrostatic peptide loading and adjuvant conjugation to boost dendritic-cell antigen presentation and T cell activation.

A 5-40 mg oral esketamine regimen over at least 28 days balances symptom relief with lower mutagenicity risk in neuropsychiatric care.

A protective freeze-drying matrix preserves nanodroplet size, distribution, and fluorinated compound concentration for longer shelf life.

PEG-OAC and DEF-OAC-PEG nanozymes raise NAD+, lower intracellular iron, and reduce oxidative stress to improve mitochondrial function.

Crystallizing insulin lispro at alkaline pH with controlled zinc levels overcomes restrictive phenolic stabilizer requirements.

Cucurbituril reduces electrostatic attraction during one-pot synthesis, resolving uniformity and complexity trade-offs for reliable gene transfer.

Chemical modification of daidzein at the 7-OH position improves water solubility and bioavailability to treat cardiovascular diseases.

Segmented contrast agents resolve specificity trade-offs by using peptide-functionalized shells to target bone cells and inhibit osteoclast activity.

A breath-powered dry powder inhaler uses a moveable sled mechanism to deagglomerate formulations for pulmonary delivery.

Polymer-coated ion-exchange resin microbeads segment drug delivery to resolve the contradiction between rapid absorption and prolonged therapeutic stability.

Energy discriminating detector analyzes spectral characteristics of administered contrast agents to generate volumetric image data.

Spray-dried solid dispersions disperse macrocyclic compounds in polymer matrices to resolve poor solubility and bioavailability limitations.

Crystalline therapeutic agents resist degradation and plasticization during sterilization, stabilizing release kinetics compared to amorphous forms.

Reactive electrophile peptides covalently bind DUOX1 cysteine residues to inhibit enzyme activity.

Segmenting hypodermic needles into micro-arrays and embedding porous particles in the matrix resolves pain and process consistency issues.

Controlled crystallization of bis-choline tetrathiomolybdate reduces impurity formation during tableting, ensuring storage stability.

A drug delivery formulation combines biodegradable polymer granules with a temperature-sensitive hydrogel to control release rates.

A combination of Opuntia ficus indica and Oryza sativa extracts inhibits the 5-alpha reductase enzyme through synergistic anti-proliferative effects.

A nutritional composition combining non-psychotropic cannabinoids with xanthines delivers fast-acting cognitive enhancement.

Segmented silica carriers reduce off-target toxicity while maintaining drug payload capacity.

Stretching a dried drug film fractures it into angular microstructures that breach the stratum corneum, resolving yield and penetration trade-offs.

Alkyl hydroxyalkylcellulose ether matrices stabilize fesoterodine hydrogen fumarate, eliminating refrigeration needs.

An enzymatic hydrogel implant attracts and traps residual cancer cells, reducing metastasis risk while sparing healthy tissue from systemic chemotherapy.

Temporary poly-L-lactic acid gel filling reduces crevicular fluid flow to deliver antimicrobial agents effectively into anaerobic infection sites.

Blocking CX3CL1 in endothelial cells reduces immunosuppression, improving anti-VEGF therapy efficacy against cancer.